Renectin Antiscar is a revolutionary RNA-based scar prevention patch that has shown promising results in clinical trials. With 83% scar volume reduction and 8 out of 10 patients reporting improved outcomes, our flagship product is poised to change the way we approach scar prevention. Approved for sa...See more
Headquarter Singapore |
Countries of operation Singapore |
Year founded 2022 (2 years) |
Funding status Private |
Company type SME |
Chief Scientific Advisor, Co-founder